Fresenius reported €413M in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Akzo Nobel AKZA:NA € 164M 97M
Alcon AG ALC:SW 2M 149M
AstraZeneca AZN:LN -1652M 2202M
BASF BAS:GR € 1253M 401M
Bayer BAYN:GR € 85M 2420M
Davita Healthcare Partners DVA:US $ 259.75M 34.07M
DSM DSM:NA € 56M 126M
E.ON EOAN:GR 1.24B 511M
Fresenius FRE:GR € 413M 58M
Fresenius Medical Care FME:GR € 273M 54.42M
Fresenius Medical Care FMS:US $ 273M 54.42M
Getinge GETIB:SS SK 757M 40M
Givaudan GIVN:VX 481M 151M
GlaxoSmithKline GSK:LN 1168M 227M
GN Store Nord GN:DC DK 433M 6M
GRIFOLS GRF:SM € 136.88M 6.94M
Hikma Pharmaceutical HIK:LN 248M 29M
Lonza Group LONN:SW 319M 73M
Merck MRK:GR € 761M 16M
Novartis NOVN:VX SF 2758M 138M
Philips PHIA:NA € 2973M 2822M
RWE RWE:GR € 1376M 839M
William Demant Holding WDH:DC 1.17B 172M